An experimental approach to the generation of human embryonic stem cells equivalents

Molecular Biotechnology

Volumn 56, Issue 1, 2014, Pages 12-37

  Skowron, Katarzyna ^a   Tomsia, Marcin ^a   Czekaj, Piotr ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Adult stem cells; Human embryonic stem cells; Induced pluripotent stem cells; Pluripotency; Somatic cell reprogramming

Indexed keywords

RNA;

ADULT STEM CELLS; HUMAN EMBRYONIC STEM CELLS; INDUCED PLURIPOTENT STEM CELLS; PLURIPOTENCY; SOMATIC CELLS;

STEM CELLS;

ADENOVIRUS VECTOR; CELL EXTRACT; CELL MARKER; CHEMICAL COMPOUND; LENTIVIRUS VECTOR; MICRORNA; PLASMID VECTOR; PROTEIN; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR;

CELL FUSION; CELL NUCLEUS TRANSPLANTATION; DNA TRANSPOSITION; EMBRYONIC STEM CELL; EXPERIMENTAL STUDY; EXPRESSION VECTOR; GENE EXPRESSION SYSTEM; GENETIC TRANSDUCTION; HUMAN; ISOLATION PROCEDURE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PROFESSIONAL KNOWLEDGE; REGENERATIVE MEDICINE; REVIEW; SEPARATION TECHNIQUE; SOMATIC CELL; VIRAL GENE DELIVERY SYSTEM;

CELL ENGINEERING; CELL FUSION; EMBRYONIC STEM CELLS; GENETIC VECTORS; HUMANS; LENTIVIRUS; NUCLEAR REPROGRAMMING; NUCLEAR TRANSFER TECHNIQUES; REGENERATIVE MEDICINE; RETROVIRIDAE; TRANSDUCTION, GENETIC;

EID: 84896305930     PISSN: 10736085     EISSN: 15590305     Source Type: Journal    
DOI: 10.1007/s12033-013-9702-4     Document Type: Review

References (199)

1. Patel, M., & Yang, S. (2010). Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Reviews, 6(3), 367-380.
2. Shao, L., & Wu, W. S. (2010). Gene-delivery systems for iPS cell generation. Expert Opinion on Biological Therapy, 10(2), 231-242.
3. Lo, B., & Parham, L. (2009). Ethical issues in stem cell research. Endocrine Reviews, 30(3), 204-213.
4. Young, H. E., & Black, A. C., Jr. (2004). Adult stem cells. The Anatomical Record. Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 276 (1), 75-102.
5. Ferro, F., Spelat, R., D'Aurizio, F., Puppato, E., Pandolfi, M., et al. (2012). Dental pulp stem cells differentiation reveals new insights in Oct4A dynamics. PLoS One, 7(7), e41774. doi:10.1371/journal.pone.0041774.
6. Arumugam, S. B., Trentz, O. A., Arikketh, D., Senthinathan, V., Rosario, B., & Mohandas, P. V. (2011). Detection of embryonic stem cell markers in adult human adipose tissue-derived stem cells. Indian Journal of Pathology and Microbiology, 54(3), 501-508.
7. Pauklin, M., Thomasen, H., Pester, A., Steuhl, K. P., & Meller, D. (2011). Expression of pluripotency and multipotency factors in human ocular surface tissues. Current Eye Research, 36(12), 1086-1097.
8. Knoepflera, P. S. (2009). Deconstructing stem cell tumorigenicity: A roadmap to safe regenerative medicine. Stem Cells, 27(5), 1050-1056.
9. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K. (2008). Induced pluripotent stem cells generated without viral integration. Science, 322, 945-949.
10. Yang, R., Jiang, M., Kumar, S. M., Xu, T., Wang, F., Xiang, L., et al. (2011). Generation of melanocytes from induced pluripotent stem cells. The Journal of Investigative Dermatology, 131(12), 2458-2466.
11. Wobus, M. A., & Boheler, K. R. (2005). Embryonic stem cells: Prospects for developmental biology and cell therapy. Physiological Reviews, 85, 635-678.
12. Yamanaka, S., & Blau, H. M. (2010). Nuclear reprogramming to a pluripotent state by three approaches. Nature, 465(7299), 704-712.
13. Tannenbaum, S. E., Turetsky, T. T., Singer, O., Aizenman, E., Kirshberg, S., Ilouz, N., et al. (2012). Derivation of xeno-free and GMP-grade human embryonic stem cells-Platforms for future clinical applications. PLoS One, 7(6), e35325. doi:10.1371/journal.pone.0035325.
14. Henderson, J. K., Draper, J. S., Baillie, H. S., Fishel, S., Thomson, J. A., Moore, H., et al. (2002). Preimplantation human embros and embryonic stem cell show comparable expression of stage-specific embryonic antigens. Stem Cells, 20, 329-337. (Pubitemid 34765092)
15. Muramatsu, T., & Muramatsu, H. (2004). Carbohydrate antigens expressed on stem cells and early embryonic cells. Glycoconjugate Journal, 21 (1-2), 41-45.
16. Kudo, T., Kaneko, M., Iwasaki, H., Togayachi, A., Nishihara, S., Abe, K., et al. (2004). Normal embryonic and germ cell development in mice lacking alpha 1,3-fucosyltransferase IX (Fut9) which show disappearance of stage-specific embryonic antigen 1. Molecular and Cellular Biology, 24(10), 4221-4228. (Pubitemid 41070995)
17. Wright, A. J., & Andrews, P. W. (2009). Surface marker antigens in the characterization of human embryonic stem cells. Stem Cell Research, 3, 3-11.
18. Zhao, W., Ji, X., Zhang, F., Li, L., & Ma, L. (2012). Embryonic stem cell markers. Molecules, 17(6), 6196-6236.
19. King, F. W., Ritner, C., Liszewski, W., Kwan, H. C., Pedersen, A., Leavitt, A. D., et al. (2009). Subpopulations of human embryonic stem cells with distinct tissue-specific fates can be selected from pluripotent cultures. Stem Cells and Development, 18(10), 1441-1450.
20. Ji, J., Werbowetski-Ogilvie, T. E., Zhong, B., Hong, S. H., & Bhatia, M. (2009). Pluripotent transcription factors possess distinct roles in normal versus transformed human stem cells. PLoS One, 4(11), e8065. doi:10.1371/journal.pone.0008065.
21. Liu, X., Huang, J., Chen, T., Wang, Y., Xin, S., Li, J., et al. (2008). Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells. Cell Research, 18(12), 1177-1189.
22. Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., et al. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell, 122, 947-956. (Pubitemid 41345211)
23. Laursen, S. B., Mollgard, K., Olesen, C., Oliveri, R. S., Brøchner, C. B., Byskov, A. G., et al. (2007). Regional differences in expression of specific markers for human embryonic stem cells. Reproductive Biomedicine Online, 15(1), 89-98. (Pubitemid 47162101)
24. Wang, X., & Dai, J. (2010). Concise review: Isoforms of OCT4 contribute to the confusing diversity in stem cell biology. Stem Cells, 28(5), 885-893.
25. Boiani, M., & Sholer, H. R. (2005). Regulatory networks in embro-derived pluripotent stem cells. Nature Reviews Molecular Cell Biology, 6(11), 872-884.
26. Babaie, Y., Herwig, R., Greber, B., Brink, T. C., Wruck, W., Groth, D., et al. (2007). Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells, 25, 500-510. (Pubitemid 46232806)
27. Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe- Nebenius, D., Chambers, I., et al. (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct-4. Cell, 95, 379-391. (Pubitemid 28507326)
28. Taranger, C. K., Noer, A., Sorensen, A. L., Hakelien, A. M., Boquest, A. C., & Collas, P. (2005). Induction of dedifferentiation, genome wide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Molecular Biology of the Cell, 16(12), 5719-5735. (Pubitemid 41752221)
29. Kim, R. J., & Nam, J. S. (2011). OCT4 expression enhances features of cancer stem cells in a mouse model of breast cancer. Laboratory Animal Research, 27(2), 147-152.
30. Adachi, K., Suemori, H., Yasuda, S. Y., Nakatsuji, N., & Kawase, E. (2010). Role of SOX2 in maintaining pluripotency of human embryonic stem cells. Genes to Cells: Devoted to Molecular & Cellular Mechanisms, 15, 455-469.
31. Fong, H., Hohenstein, K. A., & Donovan, P. J. (2008). Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells. Stem Cells, 26, 1931-1938.
32. Guan, H., Xie, L., Leithäuser, F., Flossbach, L., Möller, P., Wirth, T., et al. (2010). KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma. Blood, 116(9), 1469-1478.
33. McConnell, B. B., & Yang, V. W. (2010). Mammalian Krüppel-like factors in health and diseases. Physiological Reviews, 90(4), 1337-1381.
34. McConnell, B. B., Kim, S. S., Yu, K., Ghaleb, A. M., Takeda, N., Manabe, I., et al. (2011). Krüppel-like factor 5 is important for maintenance of crypt architecture and barrier function in mouse intestine. Gastroenterology, 141(4), 1302-1313.
35. Nandan, M. O., & Yang, W. V. (2009). The role of Krüppel-like factors in the reprogramming of somatic cells to induced pluripotent stem cells. Histology and Histopathology, 24(10), 1343-1355.
36. Jiang, J., Chan, Y. S., Loh, Y. H., Cai, J., Tong, G. Q., Lim, C. A., et al. (2008). A core Klf circuitry regulates self-renewal of embryonic stem cells. Nature Cell Biology, 10(3), 353-360. (Pubitemid 351331023)
37. Chan, K. K., Zhang, J., Chia, N. Y., Chan, Y. S., Sim, H. S., Tan, K. S., et al. (2009). KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells. Stem Cells, 27(9), 2114-2125.
38. Jain, A. K., Allton, K., Iacovino, M., Mahen, E., Milczarek, R. J., Zwaka, T. P., et al. (2012). p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biology, 10(2), e1001268. doi:10.1371/journal.pbio.1001268.
39. Zhang, W., Geiman, D. E., Shields, J. M., Dang, D. T., Mahatan, C. S., Kaestner, K. H., et al. (2000). The gutenriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. Journal of Chemical Biology, 275, 18391-18398. (Pubitemid 30414796)
40. Zhou, Q., Hong, Y., Zhan, Q., Shen, Y., & Liu, Z. (2009). Role for Kruppel-like factor 4 in determining the outcome of p53 response to DNA damage. Cancer Research, 69(21), 8284-8292.
41. Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., et al. (2009). Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature, 460(7259), 1132-1135.
42. Martinato, F., Cesaroni, M., Amati, B., & Guccione, E. (2008). Analysis of Myc-induced histone modifications on target chromatin. PLoS One, 3(11), e3650. doi:10.1371/journal.pone.0003650.
43. Okita, K., & Yamanaka, S. (2011). Induced pluripotent stem cells: Opportunities and challenges. Philosophical Transactions of the Royal Society of London. Series B, Biological sciences, 366(1575), 2198-2207.
44. Cartwright, P., McLean, C., Sheppard, A., Rivett, D., Jones, K., & Dalton, S. (2005). LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development, 132(5), 885-896. (Pubitemid 40484924)
45. Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., et al. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnology, 26(1), 101-106.
46. Li, H. Y., Chien, Y., Chen, Y. J., Chen, S. F., Chang, Y. L., Chiang, C. H., et al. (2011). Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells. Biomaterials, 32(26), 5994-6005.
47. Nakagawa, M., Takizawa, N., Narita, M., Ichisaka, T., & Yamanaka, S. (2010). Promotion of direct reprograming by transformation-deficient Myc. PNAS, 107(32), 14152-14157.
48. Ralston, A., & Rossant, J. (2010). The genetic of induced pluripotency. Reproduction, 139, 35-44.
49. Pan, G., & Thomson, J. A. (2007). Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Research, 17, 42-49.
50. Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., et al. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell, 113(5), 631-642. (Pubitemid 36694188)
51. Ratajczak, M. Z., Zuba-Surma, E. K., Shin, D.-K., Ratajczak, J., & Kucia, M. (2008). Very small embryonic-like (VSEL) stem cells in adult organs and their potential role in rejuvenation of tissues and longevity. Experimental Gerontology, 43(11), 1009-1017.
52. Ratajczak, M. Z., Zuba-Surma, E. K., Machalinski, B., Ratajczak, J., & Kucia, M. (2008). Very small embryonic-like (VSEL) stem cells: purification from adult organs, characterization, and biological significance. Stem Cell Reviews, 4 (2), 89-99.
53. Keating, A. (2012). Mesenchymal stromal cells: New directions. Cell Stem Cell, 10(6), 709-716.
54. Horwitz, E. M., Le Blanc, K., Dominici, M., Mueller, I., Slaper- Cortenbach, I., Marini, F. C., et al. (2005). Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy, 7(5), 393-395. (Pubitemid 41671625)
55. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315-317. (Pubitemid 44269669)
56. Chinen, J., & Buckley, R. H. (2010). Transplantation immunology: Solid organ and bone marrow. Journal of Allergy and Clinical Immunology, 125(2 Suppl 2), S324-S335.
57. Kimbrel, E. A., & Lu, S. J. (2011). Potential clinical applications for human pluripotent stem cell-derived blood components. Stem Cells International, 2011, 273076. doi:10.4061/2011/273076.
58. Trounson, A., Thakar, R. G., Lomax, G., & Gibbons, D. (2011). Clinical trials for stem cell therapies. BMC Medicine, 10(9), 52. doi:10.1186/1741-7015-9-52.
59. Mihaila, S. M., Frias, A. M., Pirraco, R. P., Rada, T., Reis, R. L., Gomes, M. E., et al. (2013). Human adipose tissue-derived SSEA-4 subpopulation multi-differentiation potential towards the endothelial and osteogenic lineages. Tissue Engineering Part A, 19(1-2), 235-246. doi:10.1089/ten.TEA.2012.0092.
60. Riekstina, U., Cakstina, I., Parfejevs, V., Hoogduijn, M., Jankovskis, G., Muiznieks, I., et al. (2009). Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Review, 5 (4), 378-386.
61. Okura, H., Komoda, H., Saga, A., Kakuta-Yamamoto, A., Hamada, Y., Fumimoto, Y., et al. (2010). Properties of hepatocytelike cell clusters from human adipose tissue-derived mesenchymal stem cells. Tissue Engineering Part C Methods, 16(4), 761-770.
62. Ming, G., & Song, H. (2011). Adult neurogenesis in the mammalian brain: Significant answers and significant questions. Neuron, 70(4), 687-702.
63. Dawn, B., Tiwari, S., Kucia, M. J., Zuba-Surma, E. K., Guo, Y., Sanganalmath, S. K., et al. (2008). Transplantation of bone marrow-derived very small embryonic-like stem cells attenuates left ventricular dysfunction and remodeling after myocardial infarction. Stem Cells, 26(6), 1646-1655.
64. Alison, M. R., & Islam, S. (2009). Attributes of adult stem cells. The Journal of Pathology, 2009(217), 144-160.
65. Zuba-Surma, E. K., Wojakowski, W., Ratajczak, M. Z., & Dawn, B. (2011). Very small embryonic-like stem cells: Biology and therapeutic potential for heart repair. Antioxidants & Redox Signaling, 15(7), 1821-1834.
66. Jorgensen, C., & Noël, D. (2011). Mesenchymal stem cells in osteoarticular diseases. Regenerative Medicine, 6(6 Suppl), 44-51.
67. Highfill, S. L., Kelly, R. M., O'Shaughnessy, M. J., Zhou, Q., Xia, L., Panoskaltsis-Mortari, A., et al. (2009). Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming. Blood, 114(3), 693-701.
68. Laurenti, L., Tarnani, M., Chiusolo, P., Sora, F., & Sica, S. (2010). Allogeneic transplantation for chronic lymphocytic leukemia. Mediterranean journal of hematology and infectious diseases, 2(2), e2010026. doi:10.4084/MJHID.2010.026.
69. Broxmeyer, H. E. (2010). Umbilical cord transplantation: Epilogue. Seminars in Hematology, 47(1), 97-103.
70. Abdulrazzak, H., Moschidou, D., Jones, G., & Guillot, P. V. (2010). Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. Journal of the Royal Society, Interface, 7(Suppl 6), S689-S706.
71. Mihu, C. M., Mihu, D., Costin, N., Rus Ciucǎ, D., Suşman, S., & Ciortea, R. (2008). Isolation and characterization of stem cells from the placenta and the umbilical cord. Romanian Journal of Morphology and Embryology, 49(4), 441-446.
72. Broxmeyer, H. E. (2010). Cord blood hematopoietic stem cell transplantation. StemBook, The Stem Cell Research Community. doi:10.3824/stembook.1.52.1, StemBook [Internet]. Cambridge (MA): Harvard Stem Cell Institute; 2008. Available from: http://www.ncbi.nlm.nih.gov/books/ NBK27044/.
73. Musina, R. A., Bekchanova, E. S., Belyavskii, A. V., Grinenko, T. S., & Sukhikh, G. T. (2007). Umbilical cord blood mesenchymal stem cells. Bulletin of Experimental Biology and Medicine, 143(1), 127-131. (Pubitemid 46784890)
74. Parolini, O., Alviano, F., Bagnara, G. P., Bilic, G., Bühring, H. J., Evangelista, M., et al. (2008). Concise review: Isolation and characterization of cells from human term placenta: Outcome of the first international workshop on placenta derived stem cells. Stem Cells, 26(2), 300-311. (Pubitemid 351413589)
75. Díaz-Prado, S., Muiños-López, E., Hermida-Gómez, T., Oreiro, N., Fernández-López, C., & Blanco, F. J. (2011). Human amniotic membrane as an alternative source of stem cells for regenerative medicine. Differentiation, 81, 162-171.
76. Lee, L., Ueno, M., Van Handel, B., & Mikkola, H. K. (2010). Placenta as a newly identified source of hematopoietic stem cells. Current Opinion in Hematology, 17(4), 313-318.
77. Davydova, A. (2010). Stem cells in human amniotic fluid. Biological Bulletin, 37(5), 437-445.
78. D'Alimonte, I., Lannutti, A., Pipino, C., Di Tomo, P., Pierdomenico, L., Cianci, E., et al. (2013). Wnt signaling behaves as a "Master Regulator" in the osteogenic and adipogenic commitment of human amniotic fluid mesenchymal stem cells. Stem Cell Reviews, 9(5), 642-654. doi:10.1007/s12015-013-9436-5.
79. Rosner, M., Schipany, K., Shanmugasundaram, B., Lubec, G., & Hengstschläger, M. (2012). Amniotic fluid stem cells: Future perspectives. Stem Cells International, 2012, 741810. doi:10. 1155/2012/741810.
80. Pratama, G., Vaghjiani, V., Tee, J. Y., Liu, Y. H., Chan, J., Tan, C., et al. (2011). Changes in culture expanded human amniotic epithelial cells: Implications for potential therapeutic applications. PLoS One, 6(11), e26136. doi:10.1371/journal.pone.0026136.
81. Fong, C. Y., Chak, L. L., Biswas, A., Tan, J. H., Gauthaman, K., Chan, W. K., et al. (2011). Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Reviews, 7(1), 1-16. doi:10.1007/s12015-010-9166-x.
82. Taghizadeh, R. R., Cetrulo, K. J., & Cetrulo, C. L. (2011). Wharton's Jelly stem cells: Future clinical applications. Placenta, 32(4), 311-315.
83. Peng, J., Wang, Y., Zhang, L., Zhao, B., Zhao, Z., Chen, J., et al. (2011). Human umbilical cord Wharton's jelly-derived mesenchymal stem cells differentiate into a Schwann-cell phenotype and promote neurite outgrowth in vitro. Brain Research Bulletin, 84(3), 235-243.
84. Hare, J. M., Fishman, J. E., Gerstenblith, G., DiFede Velazquez, D. L., Zambrano, J. P., et al. (2012). Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial. The Journal of the American Medical Association, 308(22), 2369-2379.
85. Mazzini, L., Mareschi, K., Ferrero, I., Miglioretti, M., Stecco, A., Servo, S., et al. (2012). Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: A long-term safety study. Cytotherapy, 14(1), 56-60.
86. Zhou, H., Guo, M., Bian, C., Sun, Z., Yang, Z., Zeng, Y., et al. (2010). Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versushost disease: Clinical report. Biology of Blood and Marrow Transplantation, 16(3), 403-412.
87. Nejadnik, H., Hui, J. H., Feng Choong, E. P., Tai, B. C., & Lee, E. H. (2010). Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: An observational cohort study. The American Journal of Sports Medicine, 38(6), 1110-1116.
88. Venkataramana, N. K., Pal, R., Rao, S. A., Naik, A. L., Jan, M., Nair, R., et al. (2012). Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson's disease: A pilot clinical study. Stem Cells International, 2012, 931902. doi:10.1155/2012/931902.
89. Fischer-Rasokat, U., Assmus, B., Seeger, F. H., Honold, J., Leistner, D., Fichtlscherer, S., et al. (2009). A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: Final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy. Circulation: Heart Failure, 2(5), 417-423.
90. Houtgraaf, J. H., den Dekker, W. K., van Dalen, B. M., Springeling, T., de Jong, R., van Geuns, R. J., et al. (2012). First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. Journal of the American College of Cardiology, 59(5), 539-540.
91. Zhang, Z., Lin, H., Shi, M., Xu, R., Fu, J., Lv, J., et al. (2012). Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. Journal of Gastroenterology and Hepatology, 27(Suppl. 2), 112-120.
92. Hu, J., Yu, X., Wang, Z., Wang, F., Wang, L., Gao, H., et al. (2013). Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocrine Journal, 60(3), 347-357.
93. Rizzino, A. (2007). A challenge for regenerative medicine: Proper genetic programming, not cellular mimicry. Developmental Dynamics: An Official Publication of the American Association of Anatomists, 236(12), 3199-3207.
94. Christen, B., Robles, V., Raya, M., Paramonov, I., & Belmonte, J. C. I. (2010). Regeneration and reprogramming compared. BMC Biology, 8, 5. doi:10.1186/1741-7007-8-5.
95. Sugomito, K., Gordon, S. P., & Meyerowitz, E. M. (2011). Regeneration in plants and animals: Dedifferentiation, or just differentiation? Trends in Cell Biology, 21(4), 212-218.
96. Red-Horse, K., Ueno, H., Weissman, I. L., & Krasnow, M. A. (2010). Coronary arteries form by developmental reprogramming of venous cells. Nature, 464(7288), 549-553.
97. Nakagawa, T., Sharma, M., Nobeshima, Y., Braun, R. E., & Yoshida, S. (2010). Functional hierarchy and reversibility within the murine spermatogenic stem cell compartment. Science, 328(5974), 62-67.
98. Li, W. C., Rukstalls, M., Nishimura, W., Tchipashvili, V., Habener, J. F., Sharma, A., et al. (2010). Activation of pancreatic-duct-derived progenitor cells during pancreas regeneration in adult rats. Journal of Cell Science, 123, 2792-2802.
99. Zheng, Y., Begum, S., Zhang, C., Fleming, K., Masumura, C., Zhang, M., et al. (2011). Increased BrdU incorporation reflecting DNA repair, neuronal de-differentiation or possible neurogenesis in the adult cochlear nucleus following bilateral cochlear lesions in the rat. Experimental Brain Research, 210, 477-487.
100. Ono, H., Oki, Y., Bono, H., & Kano, K. (2011). Gene expression profiling in multipotent DFAT cells derived from mature adipocytes. Biochemical and Biophysical Research Communications, 407(3), 562-567.
101. Shen, J. F., Sugawara, A., Yamashita, J., Ogura, H., & Sato, S. (2011). Dedifferentiated fat cells: An alternative source of adult multipotent cells from the adipose tissues. International Journal of Oral Science, 3(3), 117-124.
102. Krause, D., & Cantley, L. G. (2005). Bone marrow plasticity revisited: Protection or differentiation in the kidney tubule? The Journal of Clinical Investigation, 115, 1705-1708.
103. Chen, Y., Wong, P. P., Sjeklocha, L., Steer, C. J., & Sahin, M. B. (2012). Mature hepatocytes exhibit unexpected plasticity by direct dedifferentiation into liver progenitor cells in culture. Hepatology, 55(2), 563-574.
104. Shoshani, O., & Zipori, D. (2011). Mammalian cell dedifferentation as a possible outcome of stress. Stem Cell Reviews, 7, 488-493.
105. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
106. Singh, U., Quintanilla, R. H., Grecian, S., Gee, K. R., Rao, M. S., & Lakshmipathy, U. (2012). Novel live alkaline phosphatase substrate for identification of pluripotent stem cells. Stem Cell Reviews, 8(3), 1021-1029.
107. Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology, 25(9), 1015-1024. (Pubitemid 47517637)
108. All, A. H., Bazley, F. A., Gupta, S., Pashai, N., Hu, C., Pourmorteza, A., et al. (2012). Human embryonic stem cell-derived oligodendrocyte progenitors aid in functional recovery of sensory pathways following contusive spinal cord injury. PLoS One, 7(10), e47645. doi:10.1371/journal.pone.0047645.
109. Shiraki, N., Yamazoe, T., Qin, Z., Ohgomori, K., Mochitate, K., Kume, K., et al. (2011). Efficient differentiation of embryonic stem cells into hepatic cells in vitro using a feeder-free basement membrane substratum. PLoS One, 6(8), e24228. doi:10.1371/journal.pone.0024228.
110. Wang, D., Morales, J. E., Calame, D. G., Alcorn, J. L., & Wetsel, R. A. (2010). Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Molecular Therapy, 18(3), 625-634.
111. Trounson, A. (2006). The production and directed differentiation of human embryonic stem cells. Endocrine Reviews, 27(2), 208-219.
112. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861-872. (Pubitemid 350138099)
113. Martins-Taylor, K., & Xu, R. H. (2012). Concise review: Genomic stability of human induced pluripotent stem cells. Stem Cells, 30(1), 22-27.
114. Chin, M. H., Mason, M. J., Xie, W., Volinia, S., Singer, M., Peterson, C., et al. (2009). Induced pluripotent stem cells and embryonic stem cell are distinguished by gene expression signatures. Cell Stem Cell, 5(1), 111-123.
115. Song, B., Smink, A. M., Jones, C. V., Callaghan, J. M., Firth, S. D., Bernard, C. A., et al. (2012). The directed differentiation of human iPS cells into kidney podocytes. PLoS One, 7(9), e46453. doi:10.1371/journal.pone.0046453.
116. Cai, J., Yang, M., Poremsky, E., Kidd, S., Schneider, J. S., & Iacovitti, L. (2010). Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats. Stem Cells and Development, 19(7), 1017-1023. doi:10.1089/scd.2009.0319.
117. Si-Tayeb, K., Noto, F. K., Nagaoka, M., Li, J., Battle, M. A., Duris, C., et al. (2010). Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology, 51(1), 297-305.
118. Wang, S., Bates, J., Li, X., Schanz, S., Chandler-Militello, D., Levine, C., et al. (2013). Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell, 12(2), 252-264. doi:10.1016/j.stem.2012.12.002.
119. Li, Y., Tsai, Y. T., Hsu, C. W., Erol, D., Yang, J., Wu, W. H., et al. (2012). Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa. Molecular Medicine, 18, 1312-1319.
120. Chamberlain, S. J., Chen, P. F., Ng, K. Y., Bourgois-Rocha, F., Lemtiri-Chlieh, F., Levine, E. S., et al. (2010). Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proceedings of the National Academy of Sciences of the United States of America, 107(41), 17668-17673.
121. Ebert, A. D., Yu, J., & Rose, F. F., Jr. (2009). Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature, 457, 277-280.
122. Chun, Y. S., Chaudhari, P., & Jang, Y. Y. (2010). Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease. International Journal of Biological Sciences, 6(7), 796-805.
123. Stadtfeld, M., & Hochedlinger, K. (2010). Induced pluripotency: History, mechanisms, and applications. Genes & Development, 24, 2239-2263.
124. Park, I. H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., et al. (2008). Disease-specific induced pluripotent stem cells. Cell, 134, 877-886.
125. Marchetto, M. C., Carromeu, C., Acab, A., Yu, D., Yeo, G. W., Mu, Y., et al. (2010). A model for neural development and treatment of rett syndrome using human induced pluripotent stem cells. Cell, 143, 527-539.
126. Carvajal-Vergara, X., Sevilla, A., D'Souza, S. L., Ang, Y. S., Schaniel, C., Lee, D. F., et al. (2010). Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature, 465, 808-812.
127. Raya, A., Rodríguez-Pizà, I., Guenechea, G., Vassena, R., Navarro, S., Barrero, M. J., et al. (2009). Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature, 460(7251), 53-59.
128. Liao, J., Wu, Z., Wang, Y., Cheng, L., Cui, C., Gao, Y., et al. (2008). Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors. Cell Research, 18 (5), 600-603. (Pubitemid 351630949)
129. Hochedlinger, K., & Plath, K. (2009). Epigenetic reprogramming and induced pluripotency. Development, 136(4), 509-523.
130. Aasen, T., Raya, A., Barrero, M. J., Garreta, E., Consiglio, A., Gonzalez, F., et al. (2008). Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nature Biotechnology, 26, 1276-1284.
131. Zhao, H. X., Li, Y., Jin, H. F., Xie, L., Liu, C., Jiang, F., et al. (2010). Rapid and efficient reprogramming of human amnion-derived cells into pluripotency by three factors OCT4/SOX2/NANOG. Differentiation, 80(2-3), 123-129.
132. Zhou, T., Benda, C., Dunzinger, S., Huang, Y., Ho, J. C., Yang, J., et al. (2012). Generation of human induced pluripotent stem cells from urine samples. Nature Protocols, 7 (12), 2080-2089.
133. Panopoulos, A. D., Ruiz, S., Yi, F., Herrerías, A., Batchelder, E. M., & Izpisua Belmonte, J. C. (2011). Rapid and highly efficient generation of induced pluripotent stem cells from human umbilical vein endothelial cells. PLoS One, 6(5), e19743. doi:10.1371/journal.pone.0019743.
134. Zhang, Z., Gao, Y., Gordon, A., Wang, Z. Z., Qian, Z., & Wu, W. S. (2011). Efficient generation of fully reprogrammed human iPS cells via polycistronic retroviral vector and a new cocktail of chemical compounds. PLoS One, 6(10), e26592. doi:10.1371/journal.pone.0026592.
135. Briggs, R., & King, T. J. (1952). Transplantation of living nuclei from blastula cells into enucleated frogs' eggs. Proceedings of the National Academy of Sciences of the United States of America, 38, 455-463.
136. Gurdon, J. B. (1962). Adult frogs derived from the nuclei of single somatic cells. Developmental Biology, 4, 256-273.
137. Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. (1997). Viable offspring derived from fetal and adult mammalian cells. Nature, 385, 810-813. (Pubitemid 27106068)
138. Wakayama, T., Perry, A. C., Zuccotti, M., Johnson, K. R., & Yanagimachi, R. (1998). Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature, 394, 369-374. (Pubitemid 28373832)
139. Hochedlinger, K., & Jaenisch, R. (2002). Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature, 415, 1035-1038.
140. Piccolo, F. M., Pereira, C. F., Cantone, I., Brown, K., Tsubouchi, T., Soza-Ried, J., et al. (2011). Using heterokaryons to understand pluripotency and reprogramming. Philosophical Transactions of the Royal Society of London. Series B, Biological sciences, 366(1575), 2260-2265.
141. Tada, M., Tada, T., Lefebvre, L., Barton, S. C., & Surani, M. A. (1997). Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. The EMBO Journal, 16, 6510-6520. (Pubitemid 27483276)
142. Tada, M., Takahama, Y., Abe, K., Nakatsuji, N., & Tada, T. (2001). Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Current Biology: CB, 11, 1553-1558.
143. Silva, J., Chambers, I., Pollard, S., & Smith, A. (2006). Nanog promotes transfer of pluripotency after cell fusion. Nature, 441, 997-1001. (Pubitemid 43980355)
144. Bru, T., Clarke, C., McGrew, M. J., Sang, H. M., Wilmut, I., & Blow, J. J. (2008). Rapid induction of pluripotency genes after exposure of human somatic cells to mouse ES cell extracts. Experimental Cell Research, 314(14), 2634-2642.
145. Freberg, C. T., Dahl, J. A., Timoskainen, S., & Collas, P. (2007). Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract. Molecular Biology of the Cell, 18(5), 1543-1553. (Pubitemid 46717539)
146. Liu, H., Ye, Z., Kim, Y., Sharkis, S., & Jang, Y. Y. (2010). Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology, 51, 1810-1819.
147. Aoki, T., Ohnishi, H., Oda, Y., Tadokoro, M., Sasao, M., Kato, H., et al. (2010). Generation of induced pluripotent stem cells from human adipose-derived stem cells without c-MYC. Tissue Engineering Part A, 16, 2197-2206.
148. Dick, E., Matsa, E., Young, L. E., Darling, D., & Denning, C. (2011). Faster generation of hiPSCs by coupling high-titer lentivirus and column-based positive selection. Nature Protocols, 6(6), 701-714.
149. Zhou, W., & Freed, C. R. (2009). Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells, 27(11), 2667-2674.
150. Gonzalez, F., Monasterio, M. B., Tiscornia, G., Pulido, N. M., Vassena, R., Morera, L. B., et al. (2009). Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proceedings of the National Academy of Sciences of the United States of America, 22(106), 8918-8922.
151. Kaji, K., Norrby, K., Paca, A., Mileikovsky, M., Mohseni, P., & Woltjen, K. (2009). Virus free induction of pluripotency and subsequent excision of reprogramming factors. Nature, 458(7239), 771-775.
152. Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., et al. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4(5), 381-384.
153. Lin, S. L., Chang, D. C., Lin, C. H., Ying, S. Y., Leu, D., & Wu, D. T. (2011). Regulation of somatic cell reprogramming through inducible mir-302 expression. Nucleic Acids Research, 39(3), 1054-1065.
154. Sugii, S., Kida, Y., Kawamura, T., Suzuki, J., Vassena, R., Yin, Y. Q., et al. (2010). Human and mouse adipose-derived cells support feeder independent induction of pluripotent stem cells. Proceedings of the National Academy of Sciences of the United States of America, 107, 3558-3563.
155. Jang, J., Yoo, J. E., Lee, J. A., Lee, D. R., Kim, J. Y., Huh, Y. J., et al. (2012). Disease-specific induced pluripotent stem cells: A platform for human disease modeling and drug discovery. Experimental & Molecular Medicine, 44(3), 202-213.
156. Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., et al. (2008). Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nature Biotechnology, 26(7), 795-797. (Pubitemid 351961456)
157. Wernig, M., Lengner, C. J., Hanna, J., Lodato, M. A., Steine, E., Foreman, R., et al. (2008). A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nature Biotechnology, 26(8), 916-924.
158. Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322(5903), 949-953.
159. Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., et al. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324(5928), 797-801.
160. Chou, B. K., Mali, P., Huang, X., Ye, Z., Dowey, S. N., Resar, L. M., et al. (2011). Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Research, 21 (3), 518-529.
161. Chang, C. W., Lai, Y. S., Pawlik, K. M., Liu, K., Sun, C. W., Li, C., et al. (2009). Polycistronic lentiviral vector for 'hit and run' reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells, 27, 1042-1049.
162. Aoi, T., Yaem, K., Nakagawa, M., Ichisaka, T., Okita, K., Takahashi, K., et al. (2008). Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science, 321(5889), 699-702.
163. Wang, W., Lin, C., Lu, D., Ning, Z., Cox, T., Melvin, D., et al. (2008). Chromosomal transposition of PiggyBac in mouse embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 105(27), 9290-9295.
164. Okita, K., & Yamanaka, S. (2010). Induction of pluripotency by defined factors. Experimental Cell Research, 316(16), 2565-2570.
165. Cary, L. C., Goebel, M., Corsaro, B. G., Wang, H. G., Rosen, E., & Fraser, M. J. (1989). Transposon mutagenesis of baculoviruses: Analysis of Trichoplusia ni transposon IFP2 insertions within the FP-locus of nuclear polyhedrosis viruses. Virology, 172(1), 156-169. (Pubitemid 19221445)
166. Fraser, M. J., Ciszczon, T., Elick, T., & Bauser, C. (1996). Precise excision of TTAA-specific lepidopteran transposons piggyBac (IFP2) and tagalong (TFP3) from the baculovirus genome in cell lines from two species of Lepidoptera. Insect Molecular Biology, 5(2), 141-151.
167. Woltjen, K., Michael, I. P., Mohseni, P., Desai, R., Mileikovsky, M., Hämäläinen, R., et al. (2009). PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 458(7239), 766-770.
168. Mermer, B., Colb, M., & Krontiris, T. G. (1987). A family of short, interspersed repeats is associated with tandemly repetitive DNA in the human genome. Proceedings of the National Academy of Sciences of the United States of America, 84(10), 3320-3324. (Pubitemid 17085395)
169. Li, Z., Yang, C. S., Nakashima, K., & Rana, T. M. (2011). Small RNA-mediated regulation of iPS cell generation. The EMBO Journal, 30(5), 823-834.
170. Anokye-Danso, F., Trivedi, C. M., Juhr, D., Gupta, M., Cui, Z., Tian, Y., et al. (2011). Highly efficient miRNA -mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell, 8(4), 376-388.
171. Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y. H., Li, H., Lau, F., et al. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cell with synthetic modified mRNA. Cell Stem Cell, 7, 618-630.
172. Kim, D., Kim, C. H., Moon, J. I., Chung, Y. G., Chang, M. Y., Han, B. S., et al. (2009). Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell, 4(6), 472-476.
173. Shi, Y., Desponts, C., Do, J. T., Hahm, H. S., Schöler, H. R., & Ding, S. (2008). Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell, 3(5), 568-574.
174. Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., et al. (2008). Dissecting direct reprogramming through integrative genomic analysis. Nature, 454(7200), 49-55. (Pubitemid 351931978)
175. Plath, K., & Lowry, W. E. (2011). Progress in understanding reprogramming to the induced pluripotent state. Nature Reviews Genetics, 12(4), 253-265.
176. Djuric, U., & Ellis, J. (2010). Epigenetics of induced pluripotency, the seven-headed dragon. Stem Cell Research & Therapy, 1(1), 3. doi:10.1186/scrt3.
177. Loh, Y. H., Wu, Q., Chew, J. L., Vega, V. B., Zhang, W., Chen, X., et al. (2006). The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nature Genetics, 38(4), 431-440.
178. Masui, S., Nakatake, Y., Toyooka, Y., Shimosato, D., Yagi, R., Takahashi, K., et al. (2007). Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nature Cell Biology, 9(6), 625-635. (Pubitemid 47214724)
179. Jackson-Grusby, L., Beard, C., Possemato, R., Tudor, M., Fambrough, D., Csankovszki, G., et al. (2001). Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nature Genetics, 27(1), 31-39. (Pubitemid 32044515)
180. Polo, J. M., Liu, S., Figueroa, M. E., Kulalert, W., Eminli, S., Tan, K. Y., et al. (2010). Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nature Biotechnology, 28(8), 848-855.
181. Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., et al. (2010). Epigenetic memory in induced pluripotent stem cells. Nature, 467(7313), 285-290.
182. Wilson, K. D., Venkatasubrahmanyam, S., Jia, F., Sun, N., Butte, A. J., & Wu, J. C. (2009). MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells and Development, 18(5), 749-758.
183. Zhang, Y., Wang, D., Chen, M., Yang, B., Zhang, F., & Cao, K. (2011). Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigenesis in the heart. PLoS One, 6(4), e19012.
184. Sullivan, G. J., Bai, Y., Fletcher, J., & Wilmut, I. (2010). Induced pluripotent stem cells: Epigenetic memories and practical implications. Molecular Human Reproduction, 16(12), 880-885.
185. Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., Eden, A., Yanuka, O., Amit, M., et al. (2000). Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Molecular Medicine, 6(2), 88-95.
186. Ho, P. J., Yen, M. L., Yet, S. F., & Yen, B. L. (2012). Current applications of human pluripotent stem cells: Possibilities and challenges. Cell Transplantation, 21(5), 801-814.
187. Miki, T. (2011). Amnion-derived stem cells: In quest of clinical applications. Stem Cell Research & Therapy, 2(3), 25. doi:10.1186/scrt66.
188. Prusa, A., Marton, E., Rosner, M., Bernaschek, G., & Hengstschläger, M. (2003). Oct-4-expressing cells in human amniotic fuid: a new source for stem cell research? Human Reproduction, 18, 1489-1493. (Pubitemid 36840959)
189. Christodoulou, I., Kolisis, F. N., Papaevangeliou, D., & Zoumpourlis, V. (2013). Comparative evaluation of human mesenchymal stem cells of fetal (Wharton's Jelly) and adult (adipose tissue) origin during prolonged in vitro expansion: considerations for cytotherapy. Stem Cells International. doi:10.1155/2013/246134.
190. Parolini, O., & Soncini, M. (2006). Human placenta: A source of progenitor/stem cells? Journal of Reproductive Medicine and Endocrinology, 3, 117-126.
191. Murphy, S., Rosli, S., Acharya, R., Mathias, L., Lim, R., Wallace, E., et al. (2010). Amnion epithelial cell isolation and characterization for clinical use. Current Protocols in Stem Cell Biology, Chapter 1, Unit 1E.6. doi:10.1002/9780470151808.sc01e06s13.
192. Portmann-Lanz, C. B., Schoeberlein, A., Huber, A., Sager, R., Malek, A., Holzgreve, W., et al. (2006). Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. American Journal of Obstetrics and Gynecology, 194, 664-673. (Pubitemid 43333137)
193. Ilancheran, S., Michalska, A., Peh, G., Wallace, E. M., Pera, M., & Manuelpillai, U. (2007). Stem cells derived from human fetal membranes display multilineage differentiation potential. Biology of Reproduction, 77, 577-588. (Pubitemid 47328622)
194. Li, H., Niederkorn, J. Y., Neelam, S., Mayhew, E., Word, R. A., McCulley, J. P., et al. (2005). Immunosuppressive factors secreted by human amniotic epithelial cells. Investigative Ophthalmology & Visual Science, 46, 900-907. (Pubitemid 41321026)
195. Niknejad, H., Peirovi, H., Jorjani, M., Ahmadiani, A., Ghanavi, J., & Seifalian, A. M. (2008). Properties of the amniotic membrane for potential use in tissue engineering. European Cells & Materials, 15, 88-99. (Pubitemid 351955733)
196. Sato, K., Ozaki, K., Mori, M., Muroi, M., & Ozawa, K. (2010). Mesenchymal stromal cells for graft versus host disease: Basic aspects and clinical outcomes. Journal of Clinical and Experimental Hematopathology, 50(2), 79-89.
197. Lubis, A. M. T., & Lubis, V. K. (2012). Adult bone marrow stem cells in cartilage therapy. Acta Medica Indonesiana (The Indonesian Journal of Internal Medicine), 44(1), 62-68.
198. Mohty, M., & Apperley, J. F. (2010). Long-term physiological side effects after allogenic bone marrow transplantation. Hematology, 2010(1), 229-236.
199. Ramos-Mejía, V., Montes, R., Bueno, C., Ayllón, V., Real, P. J., Rodríguez, R., et al. (2012). Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34? progenitors. PLoS One, 7(4), e35824. doi:10.1371/journal.pone.0035824.